1. Advanced breast cancer treatment after CDK4/6– inhibitors - the experience of a Hospital Center. (November 2022) Authors: Costa, M.; Valente, A.C.; Freitas, M.; Almeida, C.; Tavares, N.; Almeida, D.; Caeiro, C.; Augusto, I.; Sousa, I.; Barbosa, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical benefit and tolerability of CDK4/6 inhibitors in the treatment of breast cancer advanced in the geriatric population – real life data from a Hospital Center. (November 2022) Authors: Costa, M.; Valente, A.C.; Freitas, M.; Almeida, C.; Teixeira, C.; Gonçalves, M.; Tavares, N.; Almeida, D.; Caeiro, C.; Augusto, I.; Sousa, I.; Barbosa, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PAM50 genomic test in the management of early breast cancer – the importance of clinical-pathological data. (November 2022) Authors: Valente, A.; Costa, M.J.; Pinto, R.; Cirnes, L.; Augusto, I.; Schmitt, F. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗